NSEGeneral Updates13 Jul 2026 · 13 Jul 2026, 01:11 pm
General Updates
Wakefit Innovations Limited · WAKEFIT
✦ AI Summary
Wakefit Innovations Limited has informed the Exchange about the grant of 4,57,611 employee stock options under the Wakefit Employee Stock Option Plan - 2019.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Wakefit Innovations Limited has informed the Exchange about Grant of Employee Stock Options under "Wakefit Employee Stock Option Plan - 2019"
Attachments (1)
📄pdf
Download →
WAKEFIT2025_13072026131014_SE_Intimation.pdf
View document text
Date: July 13, 2026
BSE Limited, National Stock Exchange of India Limited, Exchange
Phiroze Jeejeebhoy Towers, Plaza, C-1, Block G,
Dalal Street, Mumbai- 400001, Bandra Kurla Complex, Bandra (E),
Maharashtra, India Mumbai – 400 051
BSE Scrip Code: 544642 NSE Scrip Symbol: WAKEFIT
Subject: Grant of Employee Stock Options under “Wakefit Employee Stock Option Plan - 2019 [ESOP
2019]” (“WAKEFIT ESOP-2019” / “Plan”)
Dear Sir/ Madam,
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform that the Nomination and
Remuneration Committee (“NRC”) of the Board of Directors of the Company vide resolution passed on
July 13, 2026, has approved, the grant of 4,57,611 (Four Lakh Fifty Seven Thousand Six Hundred and Eleven)
Employee Stock Options (“Options”) under the WAKEFIT ESOP-2019.
The grant of the above stock options is in line with the provisions of the SEBI (Share Based Employee Benefits
& Sweat Equity) Regulations, 2021 as amended from time to time.
The details required pursuant to with Regulation 30 of the Listing Regulations read with SEBI circular
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“Master Circular”) are enclosed hereto
as Annexure - A.
The aforesaid information shall be made available on the Company's website at: www.wakefit.co/investor-relations
You are requested to kindly take the same on record.
Thanking you.
Your faithfully,
For Wakefit Innovations Limited
(formerly known as Wakefit Innovations Private Limited)
Surbhi Sharma
Company Secretary and Compliance Officer
Membership Number: A57349
Annexure – A
The details required pursuant to Regulation 30 of the Listing Regulations read with SEBI Circular
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Sr. Particulars Details
1 Brief details of options granted; 4,57,611 (Four Lakh Fifty Seven Thousand Six Hundred
and Eleven) Employee Stock Options (“Options”) have
been granted by the Nomination and Remuneration
Committee (“NRC”) in terms of the WAKEFIT ESOP-
2019
2 Whether the scheme is in terms of Yes
SEBI (SBEB) Regulations, 2021 (if
applicable);
3 Total number of shares covered by these 4,57,611 (Four Lakh Fifty Seven Thousand Six Hundred
options; and Eleven) Options exercisable into not more than
4,57,611 (Four Lakh Fifty Seven Thousand Six Hundred
and Eleven) equity shares of face value of Re. 1/- (Rupee
One Only).
4 Pricing formula The exercise price determined is Re. 1/- per Option.
5 Options vested Not Applicable
6 Time within which option may be All vested Options shall be exercisable within a maximum
exercised period of 1 (One) year from the date of vesting of the
respective Options.
7 Options exercised
8 Money realized by exercise of options
9 The total number of shares arising as a
Not Applicable, as the present disclosure is related to
result of exercise of option
grant of stock options.
10 Options lapsed
11 Variation of terms of options
12 Brief details of significant terms Options will vest after a minimum period of 12 months
from the Grant Date and not later than 5 years. Vesting will
be as per the Letter of Grant, based on time and/or
performance criteria, and subject to continued
employment. Vesting timelines may be extended for
unauthorized or non-statutory leaves as per the ESOP
Plan. All other significant terms are governed by the
ESOP Plan of the Company.
13 Subsequent changes or cancellation Not Applicable, as the present disclosure is related to grant
or exercise of such options of stock options.
14 Diluted earnings per share pursuant to Not Applicable, as the present disclosure is related to grant
issue of equity shares on exercise of of stock options.
options.